Mutations of p53 in thyroid carcinoma with an insular component

被引:45
|
作者
Takeuchi, Y [1 ]
Daa, T
Kashima, K
Yokoyama, S
Nakayama, I
Noguchi, S
机构
[1] Oita Med Univ, Dept Pathol, Hasama, Oita 8795593, Japan
[2] Noguchi Thyroid Clin & Hosp Fdn, Beppu, Oita, Japan
关键词
D O I
10.1089/thy.1999.9.377
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thyroid carcinoma with an insular component (TCIC) is considered noteworthy in view of its peculiar histopathological features and clinicopathological behavior. The purpose of the present study was to clarify the rate of mutation in the p53 gene in TCIC as compared with rates in papillary and follicular carcinomas of the thyroid. Formalin-fixed and paraffin-embedded blocks of tissue from 46 cases of TCIC were analyzed. DNA was extracted from tissues and exons 5 through 8 of the p53 gene were amphfied by the polymerase chain reaction. Mutations were detected by analysis of single-strand conformation polymorphism. Of the 46 cases of TCIC, 6 had a mutation in exon 5, 2 in exon 7, and 5 in exon 8, while 1 case had mutations in all exons examined. The mutation rate of the p53 gene in TCIC was 38%. Immunostaining revealed overexpression of p53 in nuclei that were mainly in areas of the insular component rather than in surrounding areas of well-differentiated carcinoma. The frequency of positive immunostaining in TCIC was 53%. Considering that TCIC is intermediate between papillary plus follicular carcinoma and anaplastic carcinoma in terms of survival and the rate of mutation of the p53 gene, we can speculate that mutation in the p53 gene might be associated with the insular component and might play an important role in the clinicopathological behavior of thyroid carcinoma.
引用
收藏
页码:377 / 381
页数:5
相关论文
共 50 条
  • [1] A STUDY OF P53 MUTATIONS IN HUMAN THYROID-CARCINOMA
    WRIGHT, PA
    DAWSON, T
    BOND, J
    WYLLIE, F
    WILLIAMS, ED
    WYNFORDTHOMAS, D
    JOURNAL OF PATHOLOGY, 1991, 163 (02): : A165 - A165
  • [2] P53 mutations in thyroid carcinoma: Tidings from an old foe
    Farid, NR
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2001, 24 (07) : 536 - 545
  • [3] P53 mutations in thyroid carcinoma: Tidings from an old foe
    Nadir R. Farid
    Journal of Endocrinological Investigation, 2001, 24 : 536 - 545
  • [4] Overexpression of p53 protein and p53 mutations in oral carcinoma
    Barten, M
    Ostwald, C
    Gogacz, P
    Wukasch, Y
    Gundlach, K
    MildeLangosch, K
    Loning, T
    HEAD AND NECK CANCER - ADVANCES IN BASIC RESEARCH, 1996, 1114 : 313 - 319
  • [5] P53 mutations in human thyroid carcinomas
    Stenger, A
    Knabbe, C
    Jung, R
    Henke, RP
    Frilling, A
    Broelsch, CE
    LANGENBECKS ARCHIV FUR CHIRURGIE, 1996, : 243 - 246
  • [6] Thyroid carcinoma is characterized by genomic instability: Evidence from p53 mutations
    Shahedian, B
    Shi, YF
    Zou, MJ
    Farid, NR
    MOLECULAR GENETICS AND METABOLISM, 2001, 72 (02) : 155 - 163
  • [7] THE CANINE P53 GENE IS SUBJECT TO SOMATIC MUTATIONS IN THYROID-CARCINOMA
    DEVILEE, P
    VANLEEUWEN, IS
    VOESTEN, A
    RUTTEMAN, GR
    VOS, JH
    CORNELISSE, CJ
    ANTICANCER RESEARCH, 1994, 14 (5A) : 2039 - 2046
  • [8] p53 mutations in oral cavity carcinoma
    Ragos, Vasileios
    Mastronikolis, Nicholas S.
    Tsiambas, Evangelos
    Baliou, Evangelia
    Mastronikolis, Stylianos N.
    Tsoukalas, Nikolaos
    Patsouri, Eugenia E.
    Fotiades, Panagiotis P.
    JOURNAL OF BUON, 2018, 23 (06): : 1569 - 1572
  • [9] CARCINOMA OF THE VULVA - HPV AND P53 MUTATIONS
    LEE, YY
    WILCZYNSKI, SP
    CHUMAKOV, A
    CHIH, D
    KOEFFLER, HP
    ONCOGENE, 1994, 9 (06) : 1655 - 1659
  • [10] p53 gene mutation in thyroid carcinoma
    Ho, YS
    Tseng, SC
    Chin, TY
    Hsieh, LL
    Lin, JD
    CANCER LETTERS, 1996, 103 (01) : 57 - 63